Global Companion Diagnostic Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

REPORT SUMMARY
TABLE OF CONTENTS

Companion Diagnostic market report explains the definition, types, applications, major countries, and major players of the Companion Diagnostic market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

The report contains qualitative and quantitative analysis of the entire industry.

The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

By Player:
- Agilent Technologies
- Qiagen
- Danaher Corporation
- Abbott Laboratories
- Myriad Genetics
- Novartis
- Thermo Fisher Scientific
- Roche
- Illumina
- Sysmex Corporation
By Type:
- Assay Kits
- Reagents
By End-User:
- Pharmaceutical & Biopharmaceutical Companies
- Laboratories
- Other
By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- UK
- Spain
- France
- Italy
- Denmark
- Finland
- Norway
- Sweden
- Poland
- Russia
- Turkey
Asia-Pacific
- China
- Japan
- India
- South Korea
- Pakistan
- Bangladesh
- Indonesia
- Thailand
- Singapore
- Malaysia
- Philippines
- Vietnam
- Others
South America
- Brazil
- Colombia
- Chile
- Argentina
- Venezuela
- Peru
- Puerto Rico
- Ecuador
- Others
GCC
- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- United Arab Emirates
Africa
- Nigeria
- South Africa
- Egypt
- Algeriat
- Others
Oceania
- Australia
- New Zealand
TABLE OF CONTENT
1. Global Companion Diagnostic Executive Summary
- 1.1 Introduction
- 1.2 Market Panorama, 2022
2 Coronavirus Impact
- 2.1 Companion Diagnostic Outlook to 2028- Original Forecasts
- 2.2 Companion Diagnostic Outlook to 2028- COVID-19 Affected Forecasts
- 2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
- 3.1 Potential Market Drivers and Opportunities
- 3.2 New Challenges and Strategies
- 3.3 Short Term and Long Term Companion Diagnostic Market Trends
4 Key Inferences
5 Market Overview
- 5.1 Current Market Scenario
- 5.2 Porter's Five Forces Analysis
6 Global Companion Diagnostic Market- Recent Developments
- 6.1 Companion Diagnostic Market News and Developments
- 6.2 Companion Diagnostic Market Deals Landscape
7 Companion Diagnostic Raw Materials and Cost Structure Analysis
- 7.1 Companion Diagnostic Key Raw Materials
- 7.2 Companion Diagnostic Price Trend of Key Raw Materials
- 7.3 Companion Diagnostic Key Suppliers of Raw Materials
- 7.4 Companion Diagnostic Market Concentration Rate of Raw Materials
- 7.5 Companion Diagnostic Cost Structure Analysis
8 Global Companion Diagnostic Import and Export Analysis (Top 10 Countries)
- 8.1 Global Companion Diagnostic Import by Region (Top 10 Countries) (2017-2028)
- 8.2 Global Companion Diagnostic Export by Region (Top 10 Countries) (2017-2028)
9 Global Companion Diagnostic Market Outlook by Types and Applications to 2022
- 9.1 Global Companion Diagnostic Consumption and Growth Rate by Type (2017-2022)
- 9.2 Global Companion Diagnostic Consumption and Growth Rate by Application (2017-2022)
10 Region and Country-wise Companion Diagnostic Market Analysis and Outlook till 2022
- 10.1 Global Companion Diagnostic Consumption (2017-2022)
- 10.2 North America Consumption Analysis
- 10.3 Europe Consumption Analysis
- 10.4 APAC Consumption Analysis
- 10.5 South America Consumption Analysis
- 10.6 GCC Consumption Analysis
- 10.7 Africa Consumption Analysis
- 10.8 Oceania Consumption Analysis
11 Global Companion Diagnostic Competitive Analysis
- 11.1 Agilent Technologies
- 11.2 Qiagen
- 11.3 Danaher Corporation
- 11.4 Abbott Laboratories
- 11.5 Myriad Genetics
- 11.6 Novartis
- 11.7 Thermo Fisher Scientific
- 11.8 Roche
- 11.9 Illumina
- 11.10 Sysmex Corporation
12 Global Companion Diagnostic Market Outlook by Types and Applications to 2028
- 12.1 Global Companion Diagnostic Consumption Forecast and Growth Rate by Type (2022-2028)
- 12.2 Global Companion Diagnostic Consumption Forecast and Growth Rate by Application (2022-2028)
13 Country-wise Companion Diagnostic Market Analysis and Outlook to 2028
- 13.1 Global Companion Diagnostic Consumption Forecast (2022-2028)
- 13.2 North America Consumption Analysis
- 13.3 Europe Consumption Analysis
- 13.4 APAC Consumption Analysis
- 13.5 South America Consumption Analysis
- 13.6 GCC Consumption Analysis
- 13.7 Africa Consumption Analysis
- 13.8 Oceania Consumption Analysis
14 Conclusions
The List of Tables and Figures
- Table Definition of Companion Diagnostic
- Figure of Companion Diagnostic Picture
- Table Global Companion Diagnostic Import by Region (Top 10 Countries) (2017-2028)
- Table Global Companion Diagnostic Export by Region (Top 10 Countries) (2017-2028)
- Figure Global Assay Kits Consumption and Growth Rate (2017-2022)
- Figure Global Reagents Consumption and Growth Rate (2017-2022)
- Figure Global Pharmaceutical & Biopharmaceutical Companies Consumption and Growth Rate (2017-2022)
- Figure Global Laboratories Consumption and Growth Rate (2017-2022)
- Figure Global Other Consumption and Growth Rate (2017-2022)
- Figure Global Companion Diagnostic Consumption by Country (2017-2022)
- Table North America Companion Diagnostic Consumption by Country (2017-2022)
- Figure United States Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Canada Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Mexico Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Table Europe Companion Diagnostic Consumption by Country (2017-2022)
- Figure Germany Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure UK Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Spain Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Belgium Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure France Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Italy Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Denmark Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Finland Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Norway Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Sweden Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Poland Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Russia Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Turkey Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Table APAC Companion Diagnostic Consumption by Country (2017-2022)
- Figure China Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Japan Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure India Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure South Korea Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Pakistan Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Bangladesh Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Indonesia Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Thailand Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Singapore Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Malaysia Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Philippines Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Vietnam Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Table South America Companion Diagnostic Consumption by Country (2017-2022)
- Figure Brazil Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Colombia Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Chile Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Argentina Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Venezuela Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Peru Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Puerto Rico Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Ecuador Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Table GCC Companion Diagnostic Consumption by Country (2017-2022)
- Figure Bahrain Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Kuwait Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Oman Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Qatar Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Saudi Arabia Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure United Arab Emirates Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Table Africa Companion Diagnostic Consumption by Country (2017-2022)
- Figure Nigeria Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure South Africa Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Egypt Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure Algeria Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Table Oceania Companion Diagnostic Consumption by Country (2017-2022)
- Figure Australia Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Figure New Zealand Companion Diagnostic Consumption and Growth Rate (2017-2022)
- Table Agilent Technologies Company Details
- Table Agilent Technologies Companion Diagnostic Sales, Price, Value and Gross Profit (2017-2022)
- Table Agilent Technologies Companion Diagnostic Main Business and Markets Served
- Table Agilent Technologies Companion Diagnostic Product Portfolio
- Table Qiagen Company Details
- Table Qiagen Companion Diagnostic Sales, Price, Value and Gross Profit (2017-2022)
- Table Qiagen Companion Diagnostic Main Business and Markets Served
- Table Qiagen Companion Diagnostic Product Portfolio
- Table Danaher Corporation Company Details
- Table Danaher Corporation Companion Diagnostic Sales, Price, Value and Gross Profit (2017-2022)
- Table Danaher Corporation Companion Diagnostic Main Business and Markets Served
- Table Danaher Corporation Companion Diagnostic Product Portfolio
- Table Abbott Laboratories Company Details
- Table Abbott Laboratories Companion Diagnostic Sales, Price, Value and Gross Profit (2017-2022)
- Table Abbott Laboratories Companion Diagnostic Main Business and Markets Served
- Table Abbott Laboratories Companion Diagnostic Product Portfolio
- Table Myriad Genetics Company Details
- Table Myriad Genetics Companion Diagnostic Sales, Price, Value and Gross Profit (2017-2022)
- Table Myriad Genetics Companion Diagnostic Main Business and Markets Served
- Table Myriad Genetics Companion Diagnostic Product Portfolio
- Table Novartis Company Details
- Table Novartis Companion Diagnostic Sales, Price, Value and Gross Profit (2017-2022)
- Table Novartis Companion Diagnostic Main Business and Markets Served
- Table Novartis Companion Diagnostic Product Portfolio
- Table Thermo Fisher Scientific Company Details
- Table Thermo Fisher Scientific Companion Diagnostic Sales, Price, Value and Gross Profit (2017-2022)
- Table Thermo Fisher Scientific Companion Diagnostic Main Business and Markets Served
- Table Thermo Fisher Scientific Companion Diagnostic Product Portfolio
- Table Roche Company Details
- Table Roche Companion Diagnostic Sales, Price, Value and Gross Profit (2017-2022)
- Table Roche Companion Diagnostic Main Business and Markets Served
- Table Roche Companion Diagnostic Product Portfolio
- Table Illumina Company Details
- Table Illumina Companion Diagnostic Sales, Price, Value and Gross Profit (2017-2022)
- Table Illumina Companion Diagnostic Main Business and Markets Served
- Table Illumina Companion Diagnostic Product Portfolio
- Table Sysmex Corporation Company Details
- Table Sysmex Corporation Companion Diagnostic Sales, Price, Value and Gross Profit (2017-2022)
- Table Sysmex Corporation Companion Diagnostic Main Business and Markets Served
- Table Sysmex Corporation Companion Diagnostic Product Portfolio
- Figure Global Assay Kits Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Reagents Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Pharmaceutical & Biopharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Laboratories Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Companion Diagnostic Consumption Forecast by Country (2022-2028)
- Table North America Companion Diagnostic Consumption Forecast by Country (2022-2028)
- Figure United States Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Canada Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Mexico Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Table Europe Companion Diagnostic Consumption Forecast by Country (2022-2028)
- Figure Germany Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure UK Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Spain Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Belgium Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure France Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Italy Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Denmark Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Finland Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Norway Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Sweden Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Poland Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Russia Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Turkey Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Table APAC Companion Diagnostic Consumption Forecast by Country (2022-2028)
- Figure China Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Japan Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure India Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure South Korea Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Pakistan Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Bangladesh Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Indonesia Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Thailand Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Singapore Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Malaysia Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Philippines Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Vietnam Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Table South America Companion Diagnostic Consumption Forecast by Country (2022-2028)
- Figure Brazil Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Colombia Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Chile Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Argentina Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Venezuela Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Peru Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Puerto Rico Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Ecuador Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Table GCC Companion Diagnostic Consumption Forecast by Country (2022-2028)
- Figure Bahrain Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Kuwait Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Oman Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Qatar Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Saudi Arabia Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure United Arab Emirates Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Table Africa Companion Diagnostic Consumption Forecast by Country (2022-2028)
- Figure Nigeria Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure South Africa Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Egypt Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure Algeria Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Table Oceania Companion Diagnostic Consumption Forecast by Country (2022-2028)
- Figure Australia Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)
- Figure New Zealand Companion Diagnostic Consumption Forecast and Growth Rate (2022-2028)

Companion Diagnostic Market Report

Global Companion Diagnostic Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

1. Global Companion Diagnostic Executive Summary

2 Coronavirus Impact

3 Strategic Analytics to Boost Productivity and Profitability

4 Key Inferences

5 Market Overview

6 Global Companion Diagnostic Market- Recent Developments

7 Companion Diagnostic Raw Materials and Cost Structure Analysis

8 Global Companion Diagnostic Import and Export Analysis (Top 10 Countries)

9 Global Companion Diagnostic Market Outlook by Types and Applications to 2022

10 Region and Country-wise Companion Diagnostic Market Analysis and Outlook till 2022

11 Global Companion Diagnostic Competitive Analysis

12 Global Companion Diagnostic Market Outlook by Types and Applications to 2028

13 Country-wise Companion Diagnostic Market Analysis and Outlook to 2028

14 Conclusions

The List of Tables and Figures

Report Version Choose

Our Customers

Beyond Consulting, Future is Feasible

Quick Link

CONTACT US